HOME >> BIOLOGY >> NEWS
JGI to decode DNA of destructive plant pathogen

WALNUT CREEK, CA -- Backed by nearly $4 million in funding from three Federal agencies, researchers in California and Virginia are joining forces to learn the genetic secrets of a notorious plant pathogen that causes billions of dollars a year in damage to forests and soybean crops.

Scientists at the U.S. Department of Energy's Joint Genome Institute (JGI) in Walnut Creek and the Virginia Bioinformatics Institute (VBI) in Blacksburg will decode and study the genomes of two species of Phytophthora, which is Greek for "plant devourer." Phytophthora is a fungus-like microbe responsible for sudden oak death syndrome, soybean root rot, and a wide variety of other destructive plant diseases, including the Irish potato famine in the 1840s.

By sequencing and comparing the DNA of the two Phytophthora genomes, the scientists hope to uncover clues to virulent diseases that are attacking 17 species of trees on the West Coast, including redwoods, big leaf maples, bay trees and Douglas fir, and causing serious damage to soybean crops in the Midwest and South.

"This is an ideal opportunity for genomics to make an important contribution to solving an enormous national problem," said JGI Director Eddy Rubin. "By sequencing and studying the gene function of this pathogen, we can accelerate the diagnosis, prevention and treatment of the infections it causes."

Phytophthora ramorum, the recently identified microbe responsible for sudden oak death, and P. sojae, which causes soybean root rot, resemble fungi but are actually Stramenopiles, a group of oomycetes or "water molds."

Phytophthora microbes resist treatment by conventional pesticides and other fungus control measures. Unless effective treatments are found, foresters are concerned that P. ramorum, which has already killed tens of thousands of trees in California and Oregon, could spread to northern red oak and pin oak forests in the Midwest and East despite quarantines restricting the mo
'"/>

Contact: Charles Osolin
osolin1@llnl.gov
925-296-5643
DOE/Joint Genome Institute
16-Oct-2002


Page: 1 2 3

Related biology news :

1. JGI decodes wood & toxic waste-degrading fungus genome
2. Brain areas identified that decode emotions of others
3. Researchers decode genome of rabbit fever pathogen
4. Scientists decode DNA of bacterium that cleans up uranium contamination and generates electricity
5. DNA sequence of chromosome 7 decoded
6. Virginia Bioinformatics Institute to decode plant devourer genomes
7. Scientists decode mosquito/malaria parasite genomes
8. Rice, Brookhaven physicists decode initial stage of cell fusion
9. Gene-rich pufferfish DNA decoded
10. Scientists decode genes of microbe that thrives in toxic metals
11. Researchers decode human chromosomes 5, 16, and 19

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: JGI decode DNA destructive plant pathogen

(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: